DE602005004026D1 - Einen transkriptionsfaktor kodierendes humanes prädispositionsgen für autismus sowie dessen verwendungen - Google Patents
Einen transkriptionsfaktor kodierendes humanes prädispositionsgen für autismus sowie dessen verwendungenInfo
- Publication number
- DE602005004026D1 DE602005004026D1 DE602005004026T DE602005004026T DE602005004026D1 DE 602005004026 D1 DE602005004026 D1 DE 602005004026D1 DE 602005004026 T DE602005004026 T DE 602005004026T DE 602005004026 T DE602005004026 T DE 602005004026T DE 602005004026 D1 DE602005004026 D1 DE 602005004026D1
- Authority
- DE
- Germany
- Prior art keywords
- autism
- gene
- diagnosis
- disorder
- well
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Pain & Pain Management (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58413004P | 2004-07-01 | 2004-07-01 | |
| US584130P | 2004-07-01 | ||
| PCT/IB2005/002319 WO2006003520A2 (en) | 2004-07-01 | 2005-06-30 | Human autism predisposition gene encoding a transcription factor and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE602005004026D1 true DE602005004026D1 (de) | 2008-02-07 |
| DE602005004026T2 DE602005004026T2 (de) | 2008-12-24 |
Family
ID=35432082
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602005004026T Expired - Lifetime DE602005004026T2 (de) | 2004-07-01 | 2005-06-30 | Einen transkriptionsfaktor kodierendes humanes prädispositionsgen für autismus sowie dessen verwendungen |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20070218068A1 (de) |
| EP (1) | EP1761649B1 (de) |
| JP (1) | JP4949240B2 (de) |
| AT (1) | ATE382101T1 (de) |
| AU (1) | AU2005258838B2 (de) |
| CA (1) | CA2571365A1 (de) |
| DE (1) | DE602005004026T2 (de) |
| ES (1) | ES2299059T3 (de) |
| IL (1) | IL179751A (de) |
| WO (1) | WO2006003520A2 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011509096A (ja) * | 2008-01-09 | 2011-03-24 | イエール ユニバーシティ | 特発性自閉症のリスク増加に関連するコンタクション関連タンパク質2(cntnap2)の突然変異 |
| EP2297352A1 (de) * | 2008-06-12 | 2011-03-23 | Integragen | Verfahren zur autismusvorhersage |
| EP2358907B1 (de) * | 2008-11-12 | 2015-05-20 | University of Utah Research Foundation | Mit autismus assoziierte genetische marker |
| WO2011067296A1 (en) | 2009-12-01 | 2011-06-09 | Integragen | A combination of eight risk alleles associated with autism |
| KR101167942B1 (ko) | 2010-02-12 | 2012-07-23 | 차의과학대학교 산학협력단 | Alg12 유전자로부터 유래된 단일염기다형을 포함하는 폴리뉴클레오티드, 이를 포함하는 마이크로어레이 및 진단키트, 및 이를 이용한 자폐 스펙트럼 장애 분석방법 |
| US20130137585A1 (en) | 2010-05-04 | 2013-05-30 | Jerome Carayol | New combination of eight risk alleles associated with autism |
| CN106011237B (zh) * | 2011-02-24 | 2019-12-13 | 香港中文大学 | 多胎妊娠的分子测试 |
| CN111808943B (zh) * | 2020-06-18 | 2021-07-20 | 重庆浦洛通基因医学研究院有限公司 | 一种精神类个体化用药基因检测方法 |
-
2005
- 2005-06-30 AT AT05764390T patent/ATE382101T1/de active
- 2005-06-30 CA CA002571365A patent/CA2571365A1/en not_active Abandoned
- 2005-06-30 AU AU2005258838A patent/AU2005258838B2/en not_active Ceased
- 2005-06-30 DE DE602005004026T patent/DE602005004026T2/de not_active Expired - Lifetime
- 2005-06-30 US US11/570,543 patent/US20070218068A1/en not_active Abandoned
- 2005-06-30 JP JP2007519914A patent/JP4949240B2/ja not_active Expired - Fee Related
- 2005-06-30 WO PCT/IB2005/002319 patent/WO2006003520A2/en not_active Ceased
- 2005-06-30 ES ES05764390T patent/ES2299059T3/es not_active Expired - Lifetime
- 2005-06-30 EP EP05764390A patent/EP1761649B1/de not_active Expired - Lifetime
-
2006
- 2006-11-30 IL IL179751A patent/IL179751A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2005258838A1 (en) | 2006-01-12 |
| DE602005004026T2 (de) | 2008-12-24 |
| ATE382101T1 (de) | 2008-01-15 |
| JP2008504837A (ja) | 2008-02-21 |
| WO2006003520A2 (en) | 2006-01-12 |
| IL179751A0 (en) | 2007-05-15 |
| EP1761649B1 (de) | 2007-12-26 |
| WO2006003520A3 (en) | 2006-03-02 |
| US20070218068A1 (en) | 2007-09-20 |
| ES2299059T3 (es) | 2008-05-16 |
| JP4949240B2 (ja) | 2012-06-06 |
| EP1761649A2 (de) | 2007-03-14 |
| AU2005258838B2 (en) | 2009-05-14 |
| CA2571365A1 (en) | 2006-01-12 |
| IL179751A (en) | 2011-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX338421B (es) | Anticuerpos fosfoespecificos que reconocen la proteina tau. | |
| JO3076B1 (ar) | نظم العلاج المناعي المعتمد على حالة apoe | |
| MX354662B (es) | Anticuerpos fosfoespecificos que reconocen la tau. | |
| ATE493405T1 (de) | Pyrimidinylamidverbindungen, die die durch vla-4 vermittelte leukozytenadhäsion inhibieren | |
| DK1656458T3 (da) | Human autisme-susceptibilitetsgen og anvendelser deraf | |
| DE602005004026D1 (de) | Einen transkriptionsfaktor kodierendes humanes prädispositionsgen für autismus sowie dessen verwendungen | |
| BR112012022255A2 (pt) | composição farmaceuticaestabilizada | |
| GB2473579A (en) | Stat3 and TYK2 as drug targets for neurodegenerative diseases | |
| IL185868A0 (en) | Human autism susceptibility gene encoding a transmembrane protein and uses thereof | |
| ATE424469T1 (de) | Für prkcb1 kodierendes humanes autismus- suszeptibilitätsgen und dessen verwendung | |
| WO2006087634A3 (en) | Uses of human autism susceptibility gene encoding a kinase | |
| WO2006090288A3 (en) | Human autism susceptibility genes encoding a neurotransmitter transporter and uses thereof | |
| WO2001020025A3 (en) | Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications | |
| BRPI0509477A (pt) | compostos de sulfonamida para o tratamento de distúrbios neurodegenerativos | |
| DE602006020754D1 (de) | Carbamatverbindungen, die die durch vla-4 vermittelte leukozytenadhäsion inhibieren | |
| WO2008070311A3 (en) | Gene expression profiling of parkinson's disease | |
| WO2006003526A8 (en) | Human autism susceptibility gene encoding otoa and uses thereof | |
| WO2008070284A3 (en) | Amyloid beta peptides and methods of uses thereof | |
| ATE443160T1 (de) | Für einen spannungsgesteuerten kaliumkanal kodierendes humanes adipositas- suszeptibilitätssgen und dessen verwendung | |
| Gray et al. | 1.091 A LARGE RANDOMISED TRIAL ASSESSING QUALITY OF LIFE IN PATIENTS WITH EARLY PD: RESULTS FROM PD MED EARLY | |
| ATE440826T1 (de) | Benzoxazolonderivate, verfahren zu deren herstellung und deren anwendungen | |
| Kurita et al. | 1.089 VISUAL INFORMATION PROCESSINGS ARE SELECTIVELY IMPAIRED FROM THE EARLY STAGE OF COGNITIVE DECLINE IN HALLUCINATORY PATIENTS WITH LEWY BODY DISEASE | |
| Pagonabarraga et al. | 1.090 HALLUCINATIONS IN DRUG-NAÍVE, NEWLY-DIAGNOSED PARKINSON'S DISEASE | |
| WO2005021787A3 (en) | Human obesity susceptibility gene and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |